28.09.2016 - As CEO Ian Read hinted earlier, Pfizer has officially ditched plans to break into two separate publicly traded companies dedicated to mature or off-patent products and new...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)